Aerie Pharmaceuticals, Inc. Announces Voting Results Of 2014 Annual Meeting Of Stockholders

Published: Jun 12, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, announced voting results from the Company's Annual Meeting of Stockholders, which was held earlier today. Approximately 74 percent of outstanding shares were represented at the meeting.

Help employers find you! Check out all the jobs and post your resume.

Back to news